Could an ADHD drug beat cancer fatigue in kids?
NCT ID NCT06905587
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether methylphenidate, a drug used for ADHD, can reduce severe fatigue in people who had a brain tumor as a child or teen. Fifty survivors aged 6 and older will receive either the drug or a placebo in a crossover design. The goal is to see if it improves energy and thinking, offering a new option for a common, tough side effect.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
methylphenidate (a stimulant drug used for ADHD)
What this could lead to
If it works, this could provide an evidence-based treatment option for severe fatigue in young brain tumor survivors, improving their daily energy and quality of life.
What could go wrong
This is a small, early-phase trial (50 people) testing a drug that may cause side effects like sleep problems or appetite loss. The benefit may be modest or not apply to everyone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN TUMOR, PEDIATRIC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Aalborg University Hospital
NOT_YET_RECRUITINGAalborg, 9000, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Aarhus University Hospital
RECRUITINGAarhus, 8200, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Odense University Hospital
RECRUITINGOdense, 5000, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Rigshospitalet
RECRUITINGCopenhagen, 2100, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact